The Mayo's Convalescent Plasma Study Sparks Debate


The largest study to date on convalescent plasma provides robust evidence that transfusion is safe in hospitalized patients with COVID-19 -- except it still hasn't been published in a peer-reviewed journal. Michael Joyner, MD, principal investigator for the Expanded Access Program at Mayo Clinic and lead author on the manuscript, speaks with MedPage Today's Editor-in-Chief Marty Makary, MD, MPH, of Johns Hopkins in Baltimore, about the findings and the surrounding context. Read the full conversation right here.

0 comments